BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20940052)

  • 1. BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model.
    Shi S; Hoogaars WM; de Gorter DJ; van Heiningen SH; Lin HY; Hong CC; Kemaladewi DU; Aartsma-Rus A; ten Dijke P; 't Hoen PA
    Neurobiol Dis; 2011 Feb; 41(2):353-60. PubMed ID: 20940052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP4 inhibits myogenic differentiation of bone marrow-derived mesenchymal stromal cells in mdx mice.
    Jiqing C; Yaqin L; Yingyin L; Fei C; Huili Z; Yuling Z; Juan Y; Shanwei F; Cheng Z
    Cytotherapy; 2015 Sep; 17(9):1213-9. PubMed ID: 26276004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertoli Cells Improve Myogenic Differentiation, Reduce Fibrogenic Markers, and Induce Utrophin Expression in Human DMD Myoblasts.
    Salvadori L; Chiappalupi S; Arato I; Mancuso F; Calvitti M; Marchetti MC; Riuzzi F; Calafiore R; Luca G; Sorci G
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
    Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
    Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts.
    Gosselin MRF; Mournetas V; Borczyk M; Verma S; Occhipinti A; Róg J; Bozycki L; Korostynski M; Robson SC; Angione C; Pinset C; Gorecki DC
    Elife; 2022 Sep; 11():. PubMed ID: 36164827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
    Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
    Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
    Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with rGDF11 does not improve the dystrophic muscle pathology of mdx mice.
    Rinaldi F; Zhang Y; Mondragon-Gonzalez R; Harvey J; Perlingeiro RCR
    Skelet Muscle; 2016; 6():21. PubMed ID: 27303621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
    Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
    Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
    Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients.
    Meyer P; Notarnicola C; Meli AC; Matecki S; Hugon G; Salvador J; Khalil M; Féasson L; Cances C; Cottalorda J; Desguerre I; Cuisset JM; Sabouraud P; Lacampagne A; Chevassus H; Rivier F; Carnac G
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.
    Hindi SM; Shin J; Ogura Y; Li H; Kumar A
    PLoS One; 2013; 8(8):e72121. PubMed ID: 23977226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy.
    Xu D; Li S; Wang L; Jiang J; Zhao L; Huang X; Sun Z; Li C; Sun L; Li X; Jiang Z; Zhang L
    J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):192-208. PubMed ID: 33236534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation.
    Coenen-Stass AM; Betts CA; Lee YF; Mäger I; Turunen MP; El Andaloussi S; Morgan JE; Wood MJ; Roberts TC
    Hum Mol Genet; 2016 Sep; 25(18):3960-3974. PubMed ID: 27466195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model.
    Choi IY; Lim H; Estrellas K; Mula J; Cohen TV; Zhang Y; Donnelly CJ; Richard JP; Kim YJ; Kim H; Kazuki Y; Oshimura M; Li HL; Hotta A; Rothstein J; Maragakis N; Wagner KR; Lee G
    Cell Rep; 2016 Jun; 15(10):2301-2312. PubMed ID: 27239027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heme oxygenase-1 on the differentiation of human myoblasts and the regeneration of murine skeletal muscles after acute and chronic injury.
    Głowniak-Kwitek U; Caballero AL; Bronisz-Budzyńska I; Kozakowska M; Andrysiak K; Stępniewski J; Łoboda A; Dulak J
    Pharmacol Rep; 2023 Apr; 75(2):397-410. PubMed ID: 36918494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.